Serum uric acid and atrial fibrillation

References

• Chugh SS, Havmoeller R, Narayana K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation 2014;129:837-47
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA 2001;285:2370-5
   PubMed Web of Science ®Google Scholar
• Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53
   PubMed Web of Science ®Google Scholar
• Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003;14:666-72
   PubMed Web of Science ®Google Scholar
• Rienstra M, McManus DD, Benjamin EJ. Novel risk factors for atrial fibrillation useful for risk prediction and clinical decision making? Circulation 2012;125:e941-e946
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Vasan RS, Keyes MJ, et al. Pulse pressure and risk of new onset atrial fibrillation. JAMA 2007;297:709-15
   PubMed Web of Science ®Google Scholar
• Elezi S, Qerkini G, Bujupi L, et al. Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo-a single-center study. Anadol Kard Derg 2010;10:36-40
   PubMedGoogle Scholar
• Manolis A, Doumas M, Poulimenos L, et al. The unappreciated importance of blood pressure in recent and older atrial fibrillation trials. J Hypertens 2013;31:2109-17
   PubMed Web of Science ®Google Scholar
• Manoli AJ, Kallistratos MS, Poulimenos LE. Recent clinical trials in atrial fibrillation in hypertensive patients. Curr Hypertens Rep 2012;14:350-9
   PubMed Web of Science ®Google Scholar
• Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007;49:298-303
   PubMed Web of Science ®Google Scholar
• Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-7
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu X, Jiang L, et al. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord 2016;16:207
   PubMed Web of Science ®Google Scholar
• Chao TF, Hung CL, Chen SJ, et al. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 2013;168:4027-32
   PubMed Web of Science ®Google Scholar
• Karamanou A, Kallistratos MS, Poulimenos LE, et al. Associations between serum uric acid levels and the incidence of hypertension and atrial fibrillation. ESC Congress 2015, London; August 29–September 2. P4123 Moderated poster
   Google Scholar
• Letsas KP, Korantzopoulos P, Filippatos GS, et al. Uric acid elevation in atrial fibrillation. Hellenic J Cardiol 2010;51:209-13
   PubMed Web of Science ®Google Scholar
• Suzuki S, Sagara K, Otsuka T, et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012;76:607-11
   PubMed Web of Science ®Google Scholar
• Kawasoe S, Kubozono T, Yoshifuku S, et al. Uric acid level and prevalence of atrial fibrillation in a Japanese general population of 285,882. Circ J 2016;80:2453-9
   PubMed Web of Science ®Google Scholar
• Zhang CH, Huang DS, Shen D, et al. Association between serum uric acid levels and atrial fibrillation risk. Cell Physiol Biochem 2016;38:1589-95
   PubMed Web of Science ®Google Scholar
• Xu X, Du N, Wang R, et al. Hyperuricemia is independently associated with increased risk ofatrial fibrillation: a meta-analysis of cohort studies. Int J Cardiol 2015;184:699-702
   PubMed Web of Science ®Google Scholar
• Tamariz L, Hernandez F, Bush A, et al. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2014;11:1102-8
   PubMed Web of Science ®Google Scholar
• Kim SC, Liu J, Solomon DH. Risk of incident atrial fibrillation in gout: a cohort study. Ann Rheum Dis 2016;75:1473-8
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Korantzopoulos P, et al. Uric acid levels and atrial fibrillation in hypertensive patients. Intern Med 2011;50:799-803
   PubMed Web of Science ®Google Scholar
• Kapoor S. Beyond atrial fibrillation and heart failure: the evolving role of uric acid in cardiovascular pathologies and morbidity. Chin Med J (Engl) 2012;125:3686
   PubMed Web of Science ®Google Scholar
• Valbusa F, Bertolini L, Bonapace S, et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 2013;112:499-504
   PubMed Web of Science ®Google Scholar
• Wan YF, Zheng YL, Niu HY, et al. Uric acid levels in obstructive sleep apnea patients with atrial fibrillation. Arch Med Res 2014;45:132-7
   PubMed Web of Science ®Google Scholar
• Memetoglu ME, Kehlibar T, Yılmaz M, et al. Serum uric acid level predicts new-onset atrial fibrillation after coronary artery bypass graft operation. Eur Rev Med Pharmacol Sci 2015;19:784-9
   PubMed Web of Science ®Google Scholar
• Mantovani A, Rigolon R, Pichiri I, et al. Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. J Endocrinol Invest 2016;39:159-67
   PubMed Web of Science ®Google Scholar
• Tang RB, Dong JZ, Yan XL, et al. Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol 2014;30:1415-21
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu T, Korantzopoulos P, et al. Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis. Int J Cardiol 2016;204:103-5
   PubMed Web of Science ®Google Scholar
• Manolis AJ, Poulimenos LE. Prevention of stroke by antithrombotic therapy in patients with atrial fibrillation. J Atrial Fibr 2013;5:84-92
   Google Scholar
• Perez-Ruiz F, Becker MA. Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease. Curr Med Res Opin 2015;31(supp2):9-14
   Google Scholar
• Wachtell K, Lehto M, Eva Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol. The Losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol 2005;45:712-19
   PubMed Web of Science ®Google Scholar
• Díez J. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension. Clin Ther 2006;28:832-48
   PubMed Web of Science ®Google Scholar
• Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004;65:1041-9
   PubMed Web of Science ®Google Scholar
• Manolis AJ, Grossman E, Jelakovic B, et al. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators. Clin Ther 2000;22:1186-203
   Google Scholar